Apple on the move after its results. We’re diving into the numbers and the call from the iPhone maker. Plus shedding the pounds and the prices. Novo Nordisk lowering prices for its blockbuster weight loss drugs. How an increase in competition is tipping the scales in the space.

Fast Money Disclaimer

Apple Reports Results… And Novo Nordisk’s Obesity Drug Price Cut 5/2/24

Hosted by Melissa Lee and a roundtable of top traders, “Fast Money” breaks through the noise of the day, to deliver the actionable news that matters most to investors. Fast Money airs weeknights at 5p ET on CNBC. Visit http://fastmoney.cnbc.com for additional information.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

News

May trading in the books, and after a tame inflation read this morning, investors are honing in on June trading. How to position, and where your money can get the best bang for its buck. Plus A crude reality for oil, as the commodity notches its worst month of the year. And with the latest OPEC meeting kicking off Sunday, will energy be able to turn things around?

Fast Money Disclaimer

Markets Look Towards June Trading… And Oil’s Worst Month Of The Year 5/31/24

Stocks tumbling as investors eye tomorrow’s key inflation read. But will the PCE data show the Fed’s finally getting on top of inflation. Plus… Foot Locker kicking higher after earnings. How the sneaker company is implementing their turnaround plan… and if this name can keep running.

Fast Money Disclaimer

The Next Key Piece Of Inflation Data… And Foot Locker Lacing Up 5/30/24

Rates continue their climb higher, and besides a powerhouse move in Nvidia, stocks have been feeling the pain. Will the rising rate environment continue to be a headwind for companies? Plus… Retailers rising after results. Dicks Sporting Goods, Chewy, and Abercrombie & Fitch all soaring after reporting. But will those same rising rates put pressure on the consumer? Why a former retail exec says the shopper can handle it.

Fast Money Disclaimer

Rate Rise Impact On Markets… And The Retail Resurgence 5/29/24

Is there more trouble brewing in the office real estate space? The shocking stat that could mean big problems for lenders, and why the government may need to get involved. Plus Insmed’s incredible day. The pharma stock surging as new drug trial results blow past expectations. What it could mean for the future of the company.

Fast Money Disclaimer

The Next Shoe To Drop In Office Space… And Insmed Surges On Drug Results 5/28/24

The Nasdaq closed at a record, as did a slew of stocks across sectors. But should you buy into these names now? Plus, Burger King following McDonald’s lead in offering a $5 menu, but will it be enough to draw in customers and drive up sales?

Fast Money Disclaimer

Apple Reports Results… And Novo Nordisk’s Obesity Drug Price Cut 5/2/24

Download our free app to listen on your phone